Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$357.9M
-8.7% from 2023
Prescriptions
383K
$934.72 per claim
Patients
86K
55,426 prescribers
Total spending, 2024
$358.0M
$4,165.83 per patient
Medicare prescription drug plans paid $357.9M for Janumet Xr in 2024, for 382,865 prescriptions and refills to 85,899 patients (down 8.7% from 2023). The average cost per claim was $934.72.
Texas had the highest Medicare cost for Janumet Xr in 2024: $36.4M for 35,295 claims, followed by New York ($35.3M).
Hea-Shin Kang, internal medicine in Flushing, NY, had the highest Medicare cost for Janumet Xr in 2024: 473 claims costing $373K.
Janumet Xr is made by Merck & Co., Inc. (MRK), listed in the Medicare spending data as Merck Sharp & D.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Hea-Shin Kang Flushing, NY | Internal Medicine | 473 | 64 | $373K |
| Anju Gurung Fayetteville, NC | Internal Medicine | 333 | 88 | $336K |
| Edna G Melendez Reyes |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 57,714 | 428,831 | 94,555 | $397.2M |
| 2023 | 56,274 | 397,323 | 89,278 | $392.0M |
| 2024 | 55,426 | 382,865 | 85,899 | $357.9M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Endocrinology |
| 465 |
| 81 |
| $321K |
| Hoangvy Le Gardena, CA | Family Practice | 250 | 62 | $302K |
| Jessica I Rosa Carolina, PR | Endocrinology | 379 | 90 | $297K |
| Fiby E Hanna Staten Island, NY | Endocrinology | 256 | 71 | $273K |
| Jorge R Martinez Bayamon, PR | Endocrinology | 223 | 71 | $239K |
| Benjamin Wu Brooklyn, NY | Family Practice | 341 | 50 | $235K |
| Wu Tan Flushing, NY | Internal Medicine | 455 | 59 | $227K |
| Vasdev Lohano Washington, IN | Endocrinology | 227 | 48 | $208K |
| You Suk Choi Plano, TX | Internal Medicine | 149 | 41 | $204K |
| Jean C Pujals Kury Bayamon, PR | Internal Medicine | 206 | 66 | $193K |
| Rafael A Gonzalez-Rosario Rio Piedras, PR | Internal Medicine | 296 | 56 | $190K |
| Meliza Martinez Rodriguez San Juan, PR | Endocrinology | 189 | 66 | $188K |
| Ana M Lugaro San Juan, PR | Endocrinology | 296 | 56 | $186K |
| Charles L Coats Fort Wayne, IN | Family Practice | 155 | 43 | $181K |
| Lionel Velez Montijo Bayamon, PR | Internal Medicine | 269 | 52 | $178K |
| Razmik Ohanjanian Glendale, CA | Internal Medicine | 302 | 33 | $174K |
| Renato M Sandoval Blue Springs, MO | Endocrinology | 200 | 38 | $174K |
| 1982659660 | Endocrinology | 296 | 43 | $171K |
| Saleem Mahmood Jersey City, NJ | Internal Medicine | 152 | 38 | $166K |
| Miguel P Rivera Metairie, LA | Endocrinology | 158 | 37 | $162K |
| Amir A Hassan Houston, TX | Endocrinology | 123 | 35 | $162K |
| Jose A Curet Ramos Gurabo, PR | Internal Medicine | 316 | 43 | $160K |
| Manuel Martinez San Antonio, TX | Internal Medicine | 135 | 38 | $159K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Merck Sharp & D MRK | 382,969 | $358.0M |